Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations

被引:66
|
作者
Van Gele, Mireille [1 ]
Geusens, Barbara [1 ]
Brochez, Lieve [1 ]
Speeckaert, Reinhart [1 ]
Lambert, Jo [1 ]
机构
[1] Ghent Univ Hosp, Dept Dermatol, B-9000 Ghent, Belgium
关键词
partition coefficient; reconstructed human skin model; skin permeability; stratum corneum; transdermal drug delivery; RECONSTRUCTED HUMAN EPIDERMIS; VITRO PERCUTANEOUS-ABSORPTION; IN-VITRO; STRATUM-CORNEUM; ESTRADIOL PERMEATION; EX-VIVO; SUPERSATURATED SOLUTIONS; ANIMAL SKIN; PENETRATION; METABOLISM;
D O I
10.1517/17425247.2011.568937
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Transdermal drug delivery has several known advantages over the oral route and hypodermic injections. The number of drugs that can be taken up transdermally is, however, limited owing to the innate barrier function of the skin. New transdermal drug candidates need to be tested extensively before being used on humans. In this regard, in vitro permeation methods are highly important to predict in vivo permeation of drugs. Areas covered: This review illustrates how different types of reconstructed skin models are being used as alternatives to human and pig skin for in vitro permeation testing of drugs. Insights into how various factors (including the physicochemical nature of molecules and formulations) or skin properties might affect the permeability of drugs in reconstructed skin models are provided. Also, opportunities and pitfalls of reconstructed skin models are highlighted. Expert opinion: Many studies have revealed that the permeability of reconstructed skin models is much higher compared with human excised skin. This is in accordance with the incomplete barrier found in these models. Nevertheless, the reconstructed skin models available today are useful tools for estimating the rank order of percutaneous absorption of a series of compounds with different physicochemical properties. A major challenge in the further development of reconstructed skin models for drug delivery studies is to obtain a barrier function similar to in vivo skin. Whether this goal will be achieved in the near future is uncertain and will be, in the authors' opinion, a very difficult task.
引用
收藏
页码:705 / 720
页数:16
相关论文
共 50 条
  • [21] Indications and limitations of three-dimensional models in cranio-maxillofacial surgery
    Santler, G
    Karcher, H
    Ruda, C
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 1998, 26 (01) : 11 - 16
  • [22] Potentialities and limitations of a database constructing three-dimensional virtual bone models
    Radetzki, F.
    Mendel, T.
    Noser, H.
    Stoevesandt, D.
    Roellinghoff, M.
    Gutteck, N.
    Delank, K. S.
    Wohlrab, D.
    SURGICAL AND RADIOLOGIC ANATOMY, 2013, 35 (10) : 963 - 968
  • [23] Potentialities and limitations of a database constructing three-dimensional virtual bone models
    F. Radetzki
    T. Mendel
    H. Noser
    D. Stoevesandt
    M. Röllinghoff
    N. Gutteck
    K. S. Delank
    D. Wohlrab
    Surgical and Radiologic Anatomy, 2013, 35 : 963 - 968
  • [24] Three-dimensional analyses of a perforated cylindrical drug delivery device
    Simon, Laurent
    Ospina, Juan
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 481 (1-2) : 64 - 70
  • [25] Dissolving microneedles for transdermal drug delivery: Advances and challenges
    Ita, Kevin
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 93 : 1116 - 1127
  • [26] TOWARDS SKIN COMPLIANT TRANSDERMAL DRUG DELIVERY SYSTEMS
    BODDE, HE
    TIEMESSEN, HLGM
    JUNGINGER, HE
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (02) : 150 - 150
  • [27] TRANSDERMAL DRUG DELIVERY SYSTEM WITH ENHANCED SKIN PERMEABILITY
    CHIEN, YW
    LEE, CS
    ACS SYMPOSIUM SERIES, 1987, 348 : 281 - 300
  • [28] A practical assessment of transdermal drug delivery by skin electroporation
    Prausnitz, MR
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 35 (01) : 61 - 76
  • [29] The application of skin metabolomics in the context of transdermal drug delivery
    Jinling Li
    Weitong Xu
    Yibiao Liang
    Hui Wang
    Pharmacological Reports, 2017, 69 : 252 - 259
  • [30] TRANSDERMAL DRUG DELIVERY SYSTEM WITH ENHANCED SKIN PERMEABILITY
    CHIEN, YW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 191 : 160 - INDE